{
    "eid": "2-s2.0-84992365712",
    "title": "Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children",
    "cover-date": "2016-11-04",
    "subject-areas": [
        {
            "$": "Public Health",
            "@code": "2739"
        },
        {
            "$": "Molecular Medicine",
            "@code": "1313"
        },
        {
            "$": "General Immunology and Microbiology",
            "@code": "2400"
        },
        {
            "$": "General Veterinary",
            "@code": "3400"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        }
    ],
    "keywords": [
        "Attenuated",
        "Children",
        "Encephalitis virus, Japanese",
        "Follow-up",
        "Immunization",
        "Vaccine"
    ],
    "authors": [
        "Kulkanya Chokephaibulkit"
    ],
    "citedby-count": 10,
    "ref-count": 11,
    "ref-list": [
        "Japanese encephalitis vaccines",
        "New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998",
        "Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials",
        "Safety and immunogenicity of a single administration of live-attenuated japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial",
        "Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: Randomized, controlled phase 3 immunogenicity and safety trial",
        "Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children",
        "Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: A randomized study of immunogenicity and safety",
        "Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004",
        "Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)."
    ],
    "affiliation": [
        {
            "affiliation-city": "Lyon",
            "affilname": "Sanofi Pasteur SA",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "affilname": "International AIDS Vaccine Initiative",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "affilname": "Medical Affairs &amp; Clinical Sciences Department",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "1873 Rama IV Rd",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Sanofi Pasteur",
        "Sanofi Pasteur",
        "Sanofi Pasteur",
        "Sanofi Pasteur"
    ]
}